Information Concerning Guarantor and Non-Guarantor Subsidiaries - Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 215,770	$ 199,116
Purchases of property and equipment	(127,148)	(84,557)
Investment in Gaylord Rockies joint venture	(16,309)	(50,443)
Investment in other joint ventures	(6,819)	(750)
Proceeds from sale of Peterson LOI		6,785
(Increase) decrease in restricted cash and cash equivalents	7,359	(3,517)
Other investing activities	(4,139)	1,023
Net cash flows used in investing activities	(147,056)	(131,459)
Net repayments under revolving credit facility	(235,900)	60,500
Borrowings under term loan A	200,000
Borrowings under term loan B	500,000
Repayments under term loan B	(392,500)	(3,000)
Deferred financing costs paid	(12,268)
Repayment of note payable related to purchase of AC Hotel		(6,000)
Repurchase of Company stock for retirement		(24,811)
Payment of dividends	(120,740)	(112,900)
Payment of tax withholdings for share-based compensation	(3,775)	(3,150)
Other financing activities	13	1,271
Net cash provided by (used in) financing activities	(65,170)	(88,090)
Net change in cash and cash equivalents	3,544	(20,433)
Cash and cash equivalents - unrestricted, beginning of period	59,128	56,291
Cash and cash equivalents - unrestricted, end of period	62,672	35,858
Parent Guarantor [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	124,589	141,202
Purchases of property and equipment		(8,374)
Proceeds from sale of Peterson LOI		6,785
Net cash flows used in investing activities		(1,589)
Repurchase of Company stock for retirement		(24,811)
Payment of dividends	(120,740)	(112,900)
Payment of tax withholdings for share-based compensation	(3,775)	(3,150)
Other financing activities	28	1,284
Net cash provided by (used in) financing activities	(124,487)	(139,577)
Net change in cash and cash equivalents	102	36
Cash and cash equivalents - unrestricted, beginning of period	28	23
Cash and cash equivalents - unrestricted, end of period	130	59
Issuer [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(60,255)	(51,999)
Net repayments under revolving credit facility	(235,900)	60,500
Borrowings under term loan A	200,000
Borrowings under term loan B	500,000
Repayments under term loan B	(392,500)	(3,000)
Deferred financing costs paid	(12,268)
Repayment of note payable related to purchase of AC Hotel		(6,000)
Net cash provided by (used in) financing activities	59,332	51,500
Net change in cash and cash equivalents	(923)	(499)
Cash and cash equivalents - unrestricted, beginning of period	1,234	1,578
Cash and cash equivalents - unrestricted, end of period	311	1,079
Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	64,269	23,151
Purchases of property and equipment	(63,770)	(23,304)
Other investing activities		28
Net cash flows used in investing activities	(63,770)	(23,276)
Net change in cash and cash equivalents	499	(125)
Cash and cash equivalents - unrestricted, beginning of period	23	158
Cash and cash equivalents - unrestricted, end of period	522	33
Non-Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	87,167	86,762
Purchases of property and equipment	(63,378)	(52,879)
Investment in Gaylord Rockies joint venture	(16,309)	(50,443)
Investment in other joint ventures	(6,819)	(750)
(Increase) decrease in restricted cash and cash equivalents	7,359	(3,517)
Other investing activities	(4,139)	995
Net cash flows used in investing activities	(83,286)	(106,594)
Other financing activities	(15)	(13)
Net cash provided by (used in) financing activities	(15)	(13)
Net change in cash and cash equivalents	3,866	(19,845)
Cash and cash equivalents - unrestricted, beginning of period	57,843	54,532
Cash and cash equivalents - unrestricted, end of period	$ 61,709	$ 34,687